Biography
Please note: Michelle Sleeth is currently on maternity leave. Any enquiries should be directed to Jo Gambell, the current Acting Head of Operations for the Cancer Prevention Trials Unit (CPTU).
Michelle Sleeth is the Head of Operations for the Cancer Prevention Trials Unit (CPTU). Michelle graduated from the University of Surrey in Nutrition and Dietetics. She then moved to the Section of Investigative Medicine at Imperial College London to complete her PhD and Post-doc. Michelle has worked in academic units across Imperial College London, Queen Mary University of London and King’s College London, supporting investigators to conduct high-quality clinical research in therapeutic areas including diabetes, obesity, perinatal health and cancer. One of the largest trials she has managed is the International Breast cancer Intervention Study II (IBIS-II), a large international phase III trial investigating Tamoxifen and Anastrozole. After working in the CPTU for four years, Michelle became Head of Operations for the CPTU Unit in 2020. She provides strategic and operational leadership to the CPTU core team funded by Cancer Research UK.
Research
Cancer Prevention Trials Unit
The Cancer Research UK & King’s College London Cancer Prevention Trials Unit (CPTU), funded by CRUK, specialises in research to advance cancer prevention, early diagnosis and screening
Cancer Prevention Group
Cancer Prevention Group
News
King's and NHS cancer screening trial hits 140k volunteer target
Over 140,000 people have flocked to take part in the world’s largest trial of a blood test that can detect more than 50 types of cancer, as part of the latest...
King's leads the world's largest trial of cancer blood test
The world’s largest trial of a revolutionary new blood test that can detect more than 50 types of cancer before symptoms appear has launched today.
Research
Cancer Prevention Trials Unit
The Cancer Research UK & King’s College London Cancer Prevention Trials Unit (CPTU), funded by CRUK, specialises in research to advance cancer prevention, early diagnosis and screening
Cancer Prevention Group
Cancer Prevention Group
News
King's and NHS cancer screening trial hits 140k volunteer target
Over 140,000 people have flocked to take part in the world’s largest trial of a blood test that can detect more than 50 types of cancer, as part of the latest...
King's leads the world's largest trial of cancer blood test
The world’s largest trial of a revolutionary new blood test that can detect more than 50 types of cancer before symptoms appear has launched today.